Since stemness is an established property pertaining to drug resistance and poor prognosis in cancer patients [24], these data provided an explanation for the unfavorable prognostic impact of DOCK1 over-expression in AML. The gene discussed is DOCK1; the disease is acute myeloid leukemia.